What happens when strong biology collides with weak markets? In this episode, we break down the Q2 earnings season in salmon farming, where EBIT margins have tightened, prices continue to slide, and producers are facing tough calls on investment, strategy, and survival. From Mowi’s consistency to Bakkafrost’s split results, and from Norway’s political backdrop to Scotland’s biological struggles, we look at who’s weathering the storm and who’s most exposed. Beyond the numbers, we explore the Catch-22 of salmon farming: better fish health leading to oversupply and weaker profits, just as ecological and political pressures intensify. 

Download the full report here.

For more aquaculture insights head to our Fish n’ Bits blog.